Effect of age on oral contraceptive-induced venous thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 3, 2004, Pages 259-263

  Girolami, Antonio ^a,b   Spiezia, L ^a   Girolami, B ^a   Zocca, N ^a   Luzzatto, G ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Ospedale 105   (Italy)

Author keywords

Oral contraceptives; Pro thrombotic state; Venous thrombosis

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FEDRA; ORAL CONTRACEPTIVE AGENT; OVRANET; PROGESTERONE DERIVATIVE; SECURGIN;

ADULT; AGE; ARTICLE; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; HUMAN; LEG THROMBOSIS; LUNG EMBOLISM; ORAL CONTRACEPTION; PRIORITY JOURNAL; SIDE EFFECT; VEIN THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DRUG UTILIZATION; ESTRADIOL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; PROGESTERONE CONGENERS; PROTEIN S DEFICIENCY; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 3242757504     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000308     Document Type: Article

References (29)

1. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527.
2. Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998;57:291.
3. Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: Findings in a large prospective study. BMJ 1986;292:526.
4. Girolami A, Simioni P, Girolami B, Zanardi S. The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: A study of six patients. Blood Coag Fibrinolysis 1991;2:673.
5. Girolami A, Simioni P, Sartori MT, Zanardi S. Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic. Blood Coag Fibrinolysis 1992;3:119.
6. Vandenbroucke JP, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344:1453.
7. Girolami A, Simioni P, Zanardi S, et al. Patients with APC resistance compared with those with other clotting inhibitor deficiencies show later onset of venous thrombosis during oral contraception. Clin Appl Thromb Hemost 1995;1:274.
8. Girolami A, Tormene D, Simioni P, Zanon E. Long-term use of oral contraceptive therapy in women with the prothrombin 20210 G-A polymorphism without thrombotic complications: A study of 13 women (12 heterozygotes and 1 homozygote). Thromb Res 2001;102:205.
9. de Moerloose P, Reber G, Perrier A, et al. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000;110:125.
10. Girolami A, Simioni P, Girolami B, Radossi P. Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception. Blood Coag Fibrinolysis 1996;7:590.
11. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med 1997;127:895.
12. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994;154:164.
13. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933.
14. Ridker PM, Glynn RJ, Miletich JP, et al. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 1997;126:528.
15. Kniffin WD Jr, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861.
16. Morrell MT, Dunnill MS. The post-mortem incdence of pulmonary embolism in a hospital population. Br J Surg 1968;55:347.
17. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155.
18. Simioni P, Prandoni P, Lensing AW, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000; 96:3329.
19. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198.
20. World Health Organization Collaborative study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Result of international multicentre case-control study. Lancet 1995;346:1575.
21. World Health Organization Collaborative study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582.
22. Winkler UH. Blood coagulation and oral contraceptives. A critical review. Contraception 1998;57:203.
23. Weiss G. Risk of venous thromboembolism with third-generation oral contraceptives: A review. Am J Obstet Gynecol 1999;180:295.
24. Conrad J. Biological coagulation findings in third-generation oral contraceptives. Hum Reprod Update 1999;5:672.
25. Walker AM. Newer oral contraceptives and the risk of venous thromboembolism. Contraception 1998;57:169.
26. Skegg DC. Third generation oral contraceptives. BMJ 2000;321:190.
27. Spitzer WO. The aftermath of a pill scare: Regression to reassurance. Hum Reprod Update 1999;5:736.
28. Girolami A, Spiezia L, Vianello F, et al. Changes in prescription patterns of oral contraceptives in a northern Italian province: Relation with venous thromboembolism. Clin Appl Thromb Hemost 2003;9:125.
29. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica 1999;84:59.